Friday, June 26, 2020

Carboplatin-paclitaxel becomes better option for treatment of inoperable anal cancer: Study

A new study has suggested that people with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered. 

from Zee News :Zee News - Health https://ift.tt/2BFQWgo
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Does eating dinner late really affect heart health? Experts explain

Eating dinner late is often linked to poor heart health, but cardiologists say meal timing is only one part of the bigger picture. Late or ...